These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Comparing symptoms, treatment patterns, and quality of life of ankylosing spondylitis and non-radiographic axial spondyloarthritis patients in the USA: findings from a patient and rheumatologist Survey. Hunter T; Sandoval D; Booth N; Holdsworth E; Deodhar A Clin Rheumatol; 2021 Aug; 40(8):3161-3167. PubMed ID: 33611647 [TBL] [Abstract][Full Text] [Related]
9. Anti-IL-17 Agents in the Treatment of Axial Spondyloarthritis. Atzeni F; Carriero A; Boccassini L; D'Angelo S Immunotargets Ther; 2021; 10():141-153. PubMed ID: 33977094 [TBL] [Abstract][Full Text] [Related]
10. Comparison of ankylosing spondylitis and non-radiographic axial spondyloarthritis in a multi-ethnic Asian population of Singapore. Hong C; Kwan YH; Leung YY; Lui NL; Fong W Int J Rheum Dis; 2019 Aug; 22(8):1506-1511. PubMed ID: 31090201 [TBL] [Abstract][Full Text] [Related]
11. Comparison of patients with ankylosing spondylitis (AS) and non-radiographic axial spondyloarthritis (nr-axSpA) from a single rheumatology clinic in New Delhi. Malaviya AN; Kalyani A; Rawat R; Gogia SB Int J Rheum Dis; 2015 Sep; 18(7):736-41. PubMed ID: 26172961 [TBL] [Abstract][Full Text] [Related]
12. Golimumab for the treatment of axial spondyloarthritis. Gelfer G; Perry L; Deodhar A Expert Rev Clin Immunol; 2016; 12(1):9-18. PubMed ID: 26523483 [TBL] [Abstract][Full Text] [Related]
13. Emerging Immunomodulatory Therapies and New Treatment Paradigms for Axial Spondyloarthritis. Mease P Curr Rheumatol Rep; 2019 Jun; 21(7):35. PubMed ID: 31172311 [TBL] [Abstract][Full Text] [Related]
14. New advances in the understanding and treatment of axial spondyloarthritis: from chance to choice. Dubash S; McGonagle D; Marzo-Ortega H Ther Adv Chronic Dis; 2018 Mar; 9(3):77-87. PubMed ID: 29511503 [TBL] [Abstract][Full Text] [Related]
15. New developments in ankylosing spondylitis-status in 2021. Klavdianou K; Tsiami S; Baraliakos X Rheumatology (Oxford); 2021 Dec; 60(Suppl 6):vi29-vi37. PubMed ID: 34951921 [TBL] [Abstract][Full Text] [Related]
16. Janus Kinase Inhibitors: A New Tool for the Treatment of Axial Spondyloarthritis. Paroli M; Caccavale R; Paroli MP; Spadea L; Accapezzato D Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674537 [TBL] [Abstract][Full Text] [Related]
17. Biologics for treating axial spondyloarthritis. Jones A; Ciurtin C; Ismajli M; Leandro M; Sengupta R; Machado PM Expert Opin Biol Ther; 2018 Jun; 18(6):641-652. PubMed ID: 29681195 [TBL] [Abstract][Full Text] [Related]